USPTO serial 87837997
PAN X
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BUTTON, JENNIFER JO
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PAN X?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gothenburg, SE
Gothenburg, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Margarita Wallach, Esq.
Margarita Wallach, Esq. MCCARTER & ENGLISH, LLP825 EIGHTH AVENUE, 31ST FLOORWORLDWIDE PLAZANEW YORK, NY 10019Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biologically compatible polymers, namely, hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research | ACTIVE | — |
| 005 | Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Pharmaceutical preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of bone, blood and tissue for medical purposes; Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Natural biomaterials for augmentation of bone and tissue for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 3, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 21, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 19, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 19, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 19, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 3, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 1, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 1, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 1, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 2, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 7, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 7, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 18, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 2, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Feb 28, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Feb 25, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 24, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 24, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 24, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 14, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 14, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 14, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 14, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 14, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 13, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 13, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 13, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 5, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 1, 2018 | ALIE | ASSIGNED TO LIE | — |
| Apr 14, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 14, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 14, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 20, 2018 | NWAP | NEW APPLICATION ENTERED | — |